Moneycontrol PRO
HomeNewsAurobindopharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy Infosys; IndusInd Bank may hit Rs 1125, NTPC Rs 155: Gaba

    Prakash Gaba, Technical Analyst at prakashgaba.com recommends going long in Infosys and feels that IndusInd Bank may hit Rs 1125 while NTPC may test Rs 155.

  • Buy DLF, Tata Motors, Dabur, Aurobindo Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying DLF, Tata Motors, Dabur India and Aurobindo Pharma and feels that IndusInd Bank may see upside of 5-6 percent.

  • Why pharma stocks can rally in July: SP Tulsian

    In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks and told why he has a positive stance on all pharma stocks for this coming month.

  • Buy Aurobindo Pharma, UPL, Axis Bank: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, UPL and Axis Bank.

  • Ashok Leyland may test Rs 102, Sun Pharma Rs 805: Prakash Gaba

    Prakash Gaba of prakashgaba.com is of the view that Ashok Leyland may test Rs 102 while Sun Pharma may hit Rs 805 and Jain Irrigation may head to Rs 80.

  • Buy HPCL, Aurobindo Pharma, Bank of India: Ashwani Gujral

    According to Ashwani Gujral of ashwanigujral.com, one can buy Hindustan Petroleum Corporation, Aurobindo Pharma and Bank of India.

  • Best buys: Which stocks are brokerages backing after Brexit

    On Friday, the day of Brexit referendum results, the benchmark Sensex lost nearly 1,100 points intra-day before closing 604.51 points lower. Investors' wealth in stock market took a hit of nearly Rs 1.8 lakh crore on that day.

  • Buy Tata Motors, Jet Airways, OBC, Aurobindo Pharma: Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Tata Motors, Jet Airways, Orient Bank of Commerce and Aurobindo Pharma.

  • Brexit impact limited on pharma, US biz to offset risk: Analysts

    Brokerage houses do not see any major impact of Brexit on pharma companies' earnings. In fact they have not changed their views post Friday's event, saying companies may get impacted only by currency volatility globally. According to them, any EU impact will offset by US large exposure to the US.

  • Super Six stocks you can bet on June 27

    Gaurav Bissa of LKP Securities is of the view that one may buy Bajaj Auto with a target of Rs 2750.

  • Go long in Lupin, Glenmark, Strides Shasun: SP Tulsian

    SP Tulsian of sptulsian.com recommends going long in Lupin, Glenmark Pharma, Aurobindo Pharma and Strides Shasun.

  • Hold Aurobindo Pharma for long term: Shahina Mukadam

    Shahina Mukadam, Independent Market Expert is of the view that one may hold Aurobindo Pharma with long term view.

  • Buy SBI, Motherson Sumi Systems, Aurobindo Pharma: Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying State Bank of India, Motherson Sumi Systems and Aurobindo Pharma.

  • Buy Escorts, Chambal Fertilisers, Aurobindo Pharma: Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Escorts, Chambal Fertilisers and Chemicals and Aurobindo Pharma.

  • Buy Aurobindo Pharma 720 Put, says Rahul Shah

    Rahul Shah of Motilal Oswal is of the view that one can buy Aurobindo Pharma 720 Put.

  • Buy SREI Infra, Tata Motors; sell Aurobindo Pharma: Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying SREI Infra and Tata Motors and advises selling Aurobindo Pharma.

  • Bull's Eye: Buy Coal India, SAIL, Vedanta, OBC; sell Lupin

    Vishal Malkan of malkansview.com is of the view that one can buy Oriental Bank with a target of Rs 94 and SAIL with a target of Rs 49.

  • Buy Aurobindo Pharma 740 Put, Granules India 150 Call: Bissa

    Gaurav Bissa of LKP Securities is of the view that one can buy Aurobindo Pharma 740 Put and Granules India 150 Call.

  • Buy Aurobindo Pharma at around Rs 783: Rajat Bose

    Rajat Bose of rajatkbose.com recommends buying Aurobindo Pharma at around Rs 783.

  • Buy DLF, Colgate Palmolive; Axis Bank can head higher: Sukhani

    Sudarshan Sukhani of s2analytics.com recommends buying DLF and Colgate Palmolive and feels that Axis Bank can head higher.

  • Buy Aurobindo Pharma, DLF, Biocon: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, DLF and Biocon.

  • Buy JSW Steel, Aurobindo Pharma; sell Jain Irrigation: Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying JSW Steel, UPL, Aurobindo Pharma and advises selling Jain Irrigation Systems.

  • Buy Aurobindo Pharma, Reliance Infra, Reliance Cap: Gujral

    Ashwani Gujral, Fund manager at ashwanigujral.com is of the view that one can buy Aurobindo Pharma, Reliance Infrastructure and Reliance Capital.

  • Buy Ambuja Cements; sell Idea Cellular: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Ambuja Cements and advises selling Idea Cellular and Aurobindo Pharma.

  • Infosys, HDFC Bank, Aurobindo are top picks: R Sreesankar

    R Sreesankar, Head Institutional Equities, Prabhudas Lilladher in an interview to CNBC-TV18 shared his rationale for picking Infosys, HDFC Bank, Aurobindo Pharma, Jubilant Life and Glenmark as his top picks.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347